Synteract is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. Synteract has conducted Phase I-IV studies on six continents and in 60 countries, offering expertise across multiple therapeutic areas, with notable depth in oncology, immunotherapy, ophthalmology, CNS, infectious disease, endocrinology, cardiovascular, aesthetic medicine and respiratory, among other indications. With our “Shared Work – Shared Vision” philosophy, Synteract provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data to help bring tomorrow’s treatments to patients.
Synteract has a solid understanding of the clinical development process, particularly essential for virtual, emerging, and mid-sized biopharma companies. We have rescued many studies that otherwise would not have made it to completion, but have not had any rescued from us. Our experts will help you keep your clinical trials on track and within budget. Our services include project management, clinical operations, data management, IWRS, medical and regulatory affairs expertise, medical writing and biostatistics. Our high quality standards ensure you will be working with a partner you can trust.